Bisgaier Charles PhD 4
4 · Gemphire Therapeutics Inc. · Filed Jul 26, 2019
Insider Transaction Report
Form 4
Bisgaier Charles PhD
DirectorChair & Chief Scientific Off.10% Owner
Transactions
- Award
Common Stock
2019-07-24+100,000→ 1,348,914 total
Holdings
- 19,228(indirect: By LLC)
Common Stock
- 82,220(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares are indirectly owned by the reporting person as trustee of The Charles L. Bisgaier Trust.